Section Arrow
Quote
BRTX.NASDAQ
- BioRestorative Therapies
Quotes are at least 15-min delayed:2025/09/12 00:05 EDT
Regular Hours
Last
 1.6
+0.03 (+1.91%)
Day High 
1.62 
Prev. Close
1.57 
1-M High
1.89 
Volume 
39.36K 
Bid
1.55
Ask
1.66
Day Low
1.57 
Open
1.59 
1-M Low
1.4 
Market Cap 
12.53M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.67 
20-SMA 1.59 
50-SMA 1.57 
52-W High 2.55 
52-W Low 1.21 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.26/-1.07
Enterprise Value
12.69M
Balance Sheet
Book Value Per Share
0.61
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
119.80K
Operating Revenue Per Share
0.02
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
GRIGRI Bio Inc.2.05+0.49+31.41%0.02PE
RXRXRecursion Pharmaceuticals4.85+0.31+6.83%-- 
SLXNSilexion Therapeutics Corp4.93+0.445+9.92%-- 
ADAPAdaptimmune Therapeutics plc0.0505-0.0003-0.59%-- 
ROIVRoivant Sciences Ltd14.41+0.64+4.65%1.95PE
Quotes are at least 15-min delayed：2025/09/12 00:05 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.